Skip to content
History timeline 2020 sk nexilis History timeline 2020 sk biopharmaceuticals korea exchange History timeline 2020 re 100
Previous page Next page

Jul 2020

SK Biopharmaceuticals Begins Listing on the Korea Exchange

SK Biopharmaceuticals begins listing on the Korea Exchange as the largest market debut of the year. The company plans to increase research and development of commercial and clinical-stage drugs to cure epilepsy, schizophrenia, attention deficit hyperactivity disorder and rare neurological diseases in its bid to address unmet medical needs in the United States.

More History